BlackRock Institutional Trust’s ChemoCentryx, Inc. CCXI Stock Holding History

BlackRock Institutional Trust’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.18M	Buy	429,612 +53,647	+14%	+$386K	﹤0.01%	2887
2016 Q3	$2.27M	Buy	375,965 +31,731	+9%	+$150K	﹤0.01%	2999
2016 Q2	$1.55M	Sell	344,234 -96,835	-22%	-$363K	﹤0.01%	3140
2016 Q1	$1.1M	Buy	441,069 +157,707	+56%	+$574K	﹤0.01%	3261
2015 Q4	$2.29M	Buy	283,362 +54,580	+24%	+$386K	﹤0.01%	3063
2015 Q3	$1.38M	Buy	228,782 +21,304	+10%	+$154K	﹤0.01%	3228
2015 Q2	$1.71M	Sell	207,478 -37,900	-15%	-$301K	﹤0.01%	3176
2015 Q1	$1.85M	Buy	245,378 +10,874	+5%	+$85K	﹤0.01%	3152
2014 Q4	$1.6M	Sell	234,504 -10,041	-4%	-$53.1K	﹤0.01%	3204
2014 Q3	$1.1M	Sell	244,545 -4,971	-2%	-$26.3K	﹤0.01%	3291
2014 Q2	$1.46M	Sell	249,516 -35,244	-12%	-$198K	﹤0.01%	3314
2014 Q1	$1.89M	Buy	284,760 +15,990	+6%	+$111K	﹤0.01%	3187
2013 Q4	$1.56M	Sell	268,770 -18,453	-6%	-$95.1K	﹤0.01%	3255
2013 Q3	$1.6M	Buy	287,223 +784	+0.3%	+$8.48K	﹤0.01%	3226
2013 Q2	$4.05M	Buy	+286,439	New	+$3.71M	﹤0.01%	2799

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock Institutional Trust's CCXI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its ChemoCentryx, Inc. (CCXI) stake by 14% in Q4 2016, buying an estimated $386K and bringing the position to 429,612 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

BlackRock Institutional Trust first reported a position in CCXI in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.05M in Q2 2013. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

BlackRock Institutional Trust held 429,612 shares of ChemoCentryx, Inc. worth $3.18M as of Q4 2016.
BlackRock Institutional Trust bought 53,647 ChemoCentryx, Inc. shares in Q4 2016, an estimated $386K.
ChemoCentryx, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2887 holding.
BlackRock Institutional Trust first reported a position in ChemoCentryx, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's ChemoCentryx, Inc. position peaked at $4.05M in Q2 2013.
89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.